You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《復牌表現》永泰生物(06978.HK)澄清尋求特別授權發CB 股價先升後吐14%
阿思達克 11-01 12:05
永泰生物-B(06978.HK)澄清尋求特別授權發CB,該股今早復牌略低開1仙,掉頭續漲6.7%至6.2元無以為繼,掉頭考驗10天線(4.97元),半日收5元,急吐14%,半日成交已有418萬股,涉資2,239萬元。 永泰澄清有關建議發行可換股債券(CB),向股東尋求以批准認購協議和有關交易的特別授權,並非一般授權予以配發和發行。通告指,集團擬將發行CB所得約1.023億人民幣用於EAL臨床試驗,預期將於明年底或之前動用該資金,以及將約1.977億元人民幣用作新研發和生產中心建設費用,預期將於2025年年底或之前動用餘下資金。 永泰日前公布,向基石投資者天士力醫藥發行本金額3億人民幣三年期可換股債券,年利率6%;換股價4.81元(較10月28日收市價折讓17.2%),可兌換新股佔擴大後股本11.75%,所得淨額擬用於償付業務產生營運費用、成本或開支等。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account